TY  - RPRT
TI  - Therapeutic targeting of immunometabolism in Alzheimers disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progression.
AU  - Codocedo, J. F.
AU  - Mera Reina, C.
AU  - Lin, P. B.-C.
AU  - Puntambekar, S. S.
AU  - Casali, B. T.
AU  - Jury, N.
AU  - Martinez, P.
AU  - Lasagna-Reeves, C. A.
AU  - Landreth, G. E.
PY  - 2023
DO  - 10.1101/2023.11.11.566270
UR  - https://www.biorxiv.org/content/10.1101/2023.11.11.566270v1
ID  - 10.1101/2023.11.11.566270
ER  -